The National Cancer Institute (NCI) established a partnership initiative in 2008, in response to a nationally recognized need to improve drug development processes and success rates, through enhanced collaboration among government, academia, life sciences companies, and non-profit research organizations. The initiative has culminated in the creation of the Partnership Development Office (PDO) at the Frederick National Laboratory for Cancer Research (FNLCR).
Activities of the PDO include building cross-disciplinary collaborations and teams, bridging the gap between late discovery and early development of diagnostics and therapeutics, developing cross-cutting technology platforms, and developing data standards. The overarching goal is to accelerate treatments for cancer and AIDS patients. The PDO has established numerous partnerships to date.
FNLCR has a wide range of advanced technologies and innovative platforms that support NCI’s mission, from basic research to translational and clinical studies. These include:
For additional information on FNLCR partnering opportunities, please contact: Bruce Crise Ph.D. Director Business Development Partnership Development Office Frederick National Laboratory for Cancer Research 301-846-5739 FnlcrPartnershipDevOffice@nih.gov
Typed the characters seen in the image below to continue.
Sending Mail ...
The Frederick National Lab is a Federally Funded Research and Development Center operated by SAIC-Frederick for the National Cancer Institute.
